Immediate Impact
2 from Science/Nature 54 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
2023 StandoutNature
Works of Gordon Crofoot being referenced
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
2021
Brief Report: Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B–Coinfected Adults
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Gordon Crofoot | 789 | 500 | 277 | 27 | 952 | |
| Manuel Crespo | 625 | 414 | 258 | 40 | 895 | |
| JM Gatell | 588 | 355 | 252 | 28 | 795 | |
| Duncan Churchill | 702 | 532 | 278 | 50 | 1.1k | |
| Hadewych J. M. ter Hofstede | 722 | 363 | 402 | 15 | 1.0k | |
| Paola Cicconi | 480 | 363 | 296 | 44 | 862 | |
| Nicholaos Bellos | 805 | 607 | 306 | 15 | 914 | |
| Clara Gabiano | 682 | 407 | 307 | 33 | 935 | |
| Teresa Bini | 610 | 438 | 305 | 64 | 943 | |
| Jaime E. Hernández | 703 | 523 | 465 | 35 | 1.1k | |
| Carol Worrell | 596 | 210 | 315 | 19 | 945 |
All Works
Loading papers...